Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First new drug approval for AML in 15 years.

Nature biotechnology - 8 Aug 2017

Sheridan Cormac

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Aminopyridines
Share to Aniline Compounds
Share to Drug Approval

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Pyrazines

Share to Staurosporine

Share to Triazines

Source

Identifiers

PMID: 28787411
DOI: 10.1038/nbt0817-696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First new drug approval for AML in 15 years.PMID 28787411Read ↗

In brief: Two new drugs for AML.Semantic proximity Read ↗

Update on rational targeted therapy in AMLSemantic proximity Read ↗

Novel therapeutic strategies for AML in 2012.Semantic proximity Read ↗

New strategies to treat AML: novel insights into AML survival pathways and combination therapiesSemantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

An overview of novel therapies in advanced clinical testing for acute myeloid leukemia.Semantic proximity Read ↗

How I treat acute myeloid leukemia in the era of new drugs.Semantic proximity Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.Semantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

MLL-menin and FLT3 inhibitors team up for AML.Semantic proximity Read ↗

The new era of AML therapy: current standards and emerging targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.